Scinai Immunotherapeutics Ltd. SCNI
Set alert
0.47 USD -0.05 -9.05%
At close · Oct 30
0.49 +0.02 +3.22%
After hours · Oct 30, 4:00 PM ET
0.47 Day range 0.545
0.4716 52-week range 14.60
- YTD
- -93.38%
- 1 year
- -96.77%
- Open
- 0.545
- Prev close
- 0.5185
- Mkt cap
- 1.24M
- Vol
- 52.95K
- Avg vol
- 2.15M
- EPS
- 28.07
- P/E
- 0.02
- Div yield
- 0.00%
More statistics
- Low
- 0.47
- High
- 0.545
- Forward P/E
- 0.00
- Beta
- 2.46
- Short ratio
- 0.09
- Inst. own
- 2.36%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.41
- 200-d avg
- 3.91
- 1y target
- 0.00
2Y chart
Events in this range
- Nov 22, 2024Earnings: 8.4; estimate 0; surprise —%
- Aug 21, 2026Split: 1 for 10
Signals (91)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 2026 | 3 days ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 13, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| RSI: Oversold | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
| RSI: Oversold | Jun 30, 2026 | 4 months ago |
| RSI: Oversold | Jun 22, 2026 | 4 months ago |
| RSI: Oversold | Jun 11, 2026 | 4 months ago |
| MACD: Sell Signal | May 8, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 29, 2026 | 6 months ago |
| SMA: Bearish | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 24, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 24, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 23, 2026 | 6 months ago |
| RSI: Oversold | Apr 23, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 10, 2026 | 6 months ago |
| RSI: Oversold | Mar 26, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bullish | Mar 4, 2026 | 8 months ago |
| SMA: Bearish | Mar 3, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 25, 2026 | 8 months ago |
| SMA: Bullish | Feb 24, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 5, 2026 | 8 months ago |
| SMA: Bearish | Feb 4, 2026 | 9 months ago |
| SMA: Bullish | Jan 23, 2026 | 9 months ago |
| SMA: Bearish | Jan 15, 2026 | 9 months ago |
| SMA: Bullish | Jan 14, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 6, 2026 | 9 months ago |
| RSI: Oversold | Dec 29, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 16, 2025 | 10 months ago |
| SMA: Bearish | Dec 12, 2025 | 10 months ago |
| SMA: Bullish | Dec 9, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| RSI: Oversold | Nov 20, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 29, 2025 | 1 year ago |
| SMA: Bullish | Oct 28, 2025 | 1 year ago |
| SMA: Bearish | Oct 22, 2025 | 1 year ago |
| SMA: Bullish | Oct 21, 2025 | 1 year ago |
| SMA: Bearish | Oct 9, 2025 | 1 year ago |
| SMA: Bullish | Oct 8, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 7, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 23, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 14, 2025 | 1 year ago |
| RSI: Oversold | Aug 8, 2025 | 1 year ago |
| RSI: Oversold | Jul 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 25, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 22, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 9, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 25, 2025 | 1 year ago |
| SMA: Bearish | Jun 6, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 6, 2025 | 1 year ago |
| SMA: Bullish | Jun 5, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 5, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| MACD: Sell Signal | May 29, 2025 | 1 year ago |
| SMA: Bullish | May 15, 2025 | 1 year ago |
| SMA: Bearish | May 6, 2025 | 1 year ago |
| SMA: Bullish | May 5, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 23, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| RSI: Oversold | Apr 4, 2025 | 1 year ago |
| RSI: Oversold | Mar 28, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 27, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 19, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 10, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 5, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 4, 2025 | 1 year ago |
| SMA: Bearish | Mar 3, 2025 | 1 year ago |
| SMA: Bullish | Feb 27, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 27, 2025 | 1 year ago |
| SMA: Bearish | Feb 25, 2025 | 1 year ago |
| SMA: Bullish | Feb 21, 2025 | 1 year ago |
| SMA: Bearish | Feb 10, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 10, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 6, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 22, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 19, 2024 | 1 year ago |
Key statistics
- Market cap
- 2.86M
- Enterprise value
- 10.13B
- Trailing P/E
- 1.40
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 10.06
- Price / book
- 0.00
- EPS (TTM)
- 2.40
- Beta
- 2.46
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 284.00K
- Revenue growth
- 0.00%
- Free cash flow
- -3.79M
- Total cash
- 3.08M
- Total debt
- 20.82M
- Return on equity
- 0.00%
- Shares outstanding
- 853.00K
- Short % of float
- 0.88%
- 50-day average
- 3.41
- 200-day average
- 3.91
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
SCNI Revenue — quarterly 460.00K
SCNI Net income — quarterly -2.00M
SCNI EPS — quarterly -104.00
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 22, 2024 | Sep 1, 2024 | 0.00 | 8.40 | — | — |
| Aug 15, 2024 | Jun 1, 2024 | 0.00 | -3.57 | — | — |
| Jul 2, 2024 | Mar 1, 2024 | 0.00 | -4.00 | — | — |
| May 15, 2024 | Dec 1, 2023 | 0.00 | -240.00 | — | — |
| Oct 31, 2023 | Sep 1, 2023 | 0.00 | -6.60 | — | — |
About Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Israel
- Website
- scinai.com
News
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Scinai Immunotherapeutics Announces $4.0 Million Financing Through a Private Placement and Warrant Inducement
- Why Is Scinai Immunotherapeutics Stock Gaining Tuesday?
Your note
Sign in to keep a note on SCNI — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Rhumbline Advisers | 0.19% | 1,653 | 5.54K | Sep 29, 2024 |
| Morgan Stanley | 0.03% | 255 | 854 | Sep 29, 2024 |
| Aspire Private Capital, LLC | 0.00% | 32 | 107 | Sep 29, 2024 |
| Credit Agricole S.A. | 0.00% | 42 | 140 | Sep 29, 2024 |
| UBS Group AG | 0.00% | 30 | 100 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR Portfolio Developed World ex-US ETF | 0.00% | 2 | 6 | Sep 29, 2024 |